Gemini Therapeutics announced that Dr. Tuyen Ong has been appointed to serve as an independent member of its Board of Directors. Dr. Ong is a board-certified ophthalmologist and biotechnology/pharmaceutical industry management executive. He currently serves as senior vice president and head of the ophthalmology franchise at Biogen.